Skip to main content
OpenTrials
Completed

NCT Number: NCT01935440

A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives

The goal of this study is to conduct an HIV prevention intervention to train HIV seropositive drug users to be peer health educators.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lighhouse Studies @ Peer Point

Baltimore, Maryland, 21205, United States

About this study

The primary objective of this funded research is to conduct an HIV prevention intervention to train HIV seropositive drug users to be peer health educators to: (1) recruit their high risk social network members for voluntary HIV counseling and testing (VCT) at the research clinic, (2) promote risk reduction among social network members, and (3) promote engagement in HIV care by encouraging HIV seropositive network members to schedule and keep HIV primary care appointments. There will be four types of participants in the Full Trial: 1) Index, 2) Testing Network 3) Longitudinal Network and 4) HIV positive network participants. This longitudinal study includes baseline, 6-months, and 12-month assessments

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Index

  • 18 years old or older
  • documentation of HIV positive status
  • report one of following risk behaviors in past 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex

Testing network

  • 18 or older
  • provided testing coupon provided by an index participant

Longitudinal network participant-

  • tested HIV negative at the Lighthouse via redeeming a testing coupon
  • reported interacting with index who gave the coupon at least weekly
  • report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex

Positive Networks

  • HIV positive
  • report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex

Exclusion criteria

Index- already enrolled in the study as a Network participant

Testing network- already enrolled in the study as a Network participant

Longitudinal network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant

Positive network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant

Treatment and study plan

Prevention & Testing

Behavioral

6 group sessions, 1 individual session, and 1 dyad session

Prevention & Testing Control

Behavioral

7 group sessions

Primary outcomes

  1. change in HIV medication adherence

    Time frame: 6 month

  2. change in frequency in attending HIV medical appointments

    Time frame: 6 month

Secondary outcomes

  1. change in sharing injection equipment

    Time frame: 6 month

  2. change in condom use

    Time frame: 6 month

Sponsors and collaborators

Lead sponsor

Johns Hopkins Bloomberg School of Public Health

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Acronym: P&T

Important dates

Study start
2012
Primary completion
2017
Study completion
2017
First posted
Sep 5, 2013
Registry last updated
Jul 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.